In these networks, RHO, PDE6A, 3′,5′-cyclic-GMP phosphodiesterase, and G protein alpha were in the central “nodes,” which prompt their roles as the target genes for AMD treatment. This evidence concerns the gene RHO and age-related macular degeneration.